An Open-Label Phase 1 Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects
Latest Information Update: 27 Dec 2022
At a glance
- Drugs Setanaxib (Primary)
- Indications Bile duct diseases; Diabetic neuropathies; Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- Sponsors Calliditas Therapeutics
Most Recent Events
- 08 Nov 2022 Results assessing the PK and drug-drug interactions of setanaxib tablets, presented at The Liver Meeting 2022: 73rd Annual Meeting of the American Association for the Study of Liver Diseases
- 21 May 2021 Status changed from recruiting to completed.
- 17 Jan 2021 Results published in the GenKyoTex Media Release.